Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
hemohemoFlora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Mélanie Y. Daniel et al. published in Blood Advances:
“Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease”
Title: Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease
Authors: Mélanie Y. Daniel, Antoine Rauch, Camille Paris, Emmanuelle Jeanpierre, Jenny Goudemand, Catherine Marichez, Bénédicte Pradines, Christophe Zawadzki, Annabelle Dupont, Cécile V. Denis, Peter J. Lenting, Sophie Susen, Xavier Delavenne
Read the Full Article on Blood Advances
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Apr 9, 2026, 11:15Gopal Patidar: A Global Snapshot of Gaps in Transfusion Safety and Traceability
-
Apr 8, 2026, 18:14Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey
-
Apr 8, 2026, 17:56Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
-
Apr 8, 2026, 17:46Mohamed Reda: Why Some Veins Decide to Take a ‘Detour’?
-
Apr 8, 2026, 17:39Managing Acquired Von Willebrand Syndrome in a Swine Polytrauma Model During ECLS – JTH
-
Apr 8, 2026, 17:04Heghine Khachatryan: Marfan vs LDS – Not All Aortopathies Are the Same
-
Apr 8, 2026, 17:00Frits Rosendaal Receives ISTH Grant Medal for Lifetime Contributions to Thrombosis and Hemostasis Field
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26